Chronic treatment with citalopram facilitates the effect of a challenge dose on cortical serotonin output: role of presynaptic 5-HT1A receptors

This publication has 14 references indexed in Scilit:

• Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei
  Synapse, 1993
• Comparative effects of chronic 8-OH-DPAT, gepirone and ipsapirone treatment on the sensitivity of somatodendritic 5-HT1A autoreceptors
  Neuropharmacology, 1993
• Serotonin 5‐HT_1A Autoreceptor Blockade Potentiates the Ability of the 5‐HT Reuptake Inhibitor Citalopram to Increase Nerve Terminal Output of 5‐HT In Vivo: A Microdialysis Study
  Journal of Neurochemistry, 1993
• Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: An in vivo microdialysis study
  European Journal of Pharmacology, 1992
• Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex
  Brain Research, 1992
• Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1991
• Effect of the 5-HT1A receptor agonist 8-OH-DPAT on the release of 5-HT in dorsal and median raphe-innervated rat brain regions as measured by in vivo microdialysis
  Life Sciences, 1991
• Biochemical hypotheses on antidepressant drugs: a guide for clinicians or a toy for pharmacologists?
  Psychological Medicine, 1988
• Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: Electrophysiological studies in the rat brain
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1986
• Biochemical effects and drug levels in rats after long-term treatment with the specific 5-HT-uptake inhibitor, citalopram
  Psychopharmacology, 1984